289 related articles for article (PubMed ID: 6597563)
1. Trends in the development of beta-lactam antibiotics.
Neu HC
Scand J Infect Dis Suppl; 1984; 42():7-16. PubMed ID: 6597563
[TBL] [Abstract][Full Text] [Related]
2. Use of new beta-lactam antibiotics in intraabdominal surgery.
Kager L; Nord CE
Scand J Infect Dis Suppl; 1984; 42():143-50. PubMed ID: 6335598
[TBL] [Abstract][Full Text] [Related]
3. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
5. Basic design of beta-lactam antibiotics: penams and analogues and monocyclic beta-lactams.
Ekström B
Scand J Infect Dis Suppl; 1984; 42():38-49. PubMed ID: 6335599
[TBL] [Abstract][Full Text] [Related]
6. Carbapenems and monobactams: imipenem, meropenem, and aztreonam.
Hellinger WC; Brewer NS
Mayo Clin Proc; 1999 Apr; 74(4):420-34. PubMed ID: 10221472
[TBL] [Abstract][Full Text] [Related]
7. Emergence and mechanisms of bacterial resistance in surgical infections.
Neu HC
Am J Surg; 1995 May; 169(5A Suppl):13S-20S. PubMed ID: 7755162
[TBL] [Abstract][Full Text] [Related]
8. [The new penicillins].
Borderon JC
Pediatrie; 1988; 43(5):397-404. PubMed ID: 3059311
[TBL] [Abstract][Full Text] [Related]
9. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
10. [Review of oral cephalosporins. Basis for a rational choice].
Forti IN
Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
[TBL] [Abstract][Full Text] [Related]
11. [Beta-lactamases with a wide substrate spectrum in gram negative strictly anaerobic rods].
Rokosz A; Sawicka-Grzelak A; Kot K; Pituch H; Meisel-Mikołajczyk F; Luczak M
Med Dosw Mikrobiol; 2000; 52(2):129-37. PubMed ID: 11107787
[TBL] [Abstract][Full Text] [Related]
12. [Development of beta-lactam antibiotic resistance in gram-negative bacteria and the impact of resistance on therapy].
Bedenić B
Lijec Vjesn; 1999; 121(7-8):249-57. PubMed ID: 10573961
[TBL] [Abstract][Full Text] [Related]
13. [Bacterial resistance against beta-lactam antibiotics].
Andersen BM
Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3233-9. PubMed ID: 2256036
[TBL] [Abstract][Full Text] [Related]
14. Changing patterns of hospital infections: implications for therapy. Changing mechanisms of bacterial resistance.
Neu HC
Am J Med; 1984 Jul; 77(1B):11-23. PubMed ID: 6087659
[TBL] [Abstract][Full Text] [Related]
15. Emerging trends in antimicrobial resistance in surgical infections. A review.
Neu HC
Eur J Surg Suppl; 1994; (573):7-18. PubMed ID: 7524800
[TBL] [Abstract][Full Text] [Related]
16. The incidence of beta-lactamase-producing pathogens.
Acar JF; Kitzis MD; Gutmann L
APMIS Suppl; 1989; 5():2-8. PubMed ID: 2660867
[TBL] [Abstract][Full Text] [Related]
17. Emergence of resistance in gram-negative bacilli during beta-lactam therapy: a challenge for the future.
Pechère JC
Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S17-23. PubMed ID: 2693106
[TBL] [Abstract][Full Text] [Related]
18. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
19. Carbapenems: a potent class of antibiotics.
Nicolau DP
Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
[TBL] [Abstract][Full Text] [Related]
20. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
Bedenić B
Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
